000 01338 a2200385 4500
005 20250514215906.0
264 0 _c20050328
008 200503s 0 0 eng d
022 _a1464-4096
024 7 _a10.1111/j.1464-410X.2005.05327.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aManunta, Andrea
245 0 0 _aNon-transitional cell bladder carcinomas.
_h[electronic resource]
260 _bBJU international
_cMar 2005
300 _a497-502 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdenocarcinoma
_xepidemiology
650 0 4 _aAntineoplastic Agents, Alkylating
_xtherapeutic use
650 0 4 _aCarcinoma, Squamous Cell
_xepidemiology
650 0 4 _aCyclophosphamide
_xtherapeutic use
650 0 4 _aCystectomy
_xmethods
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aPrognosis
650 0 4 _aRisk Factors
650 0 4 _aSchistosomiasis haematobia
_xcomplications
650 0 4 _aUrinary Bladder Neoplasms
_xepidemiology
700 1 _aVincendeau, Sebastien
700 1 _aKiriakou, George
700 1 _aLobel, Bernard
700 1 _aGuillé, François
773 0 _tBJU international
_gvol. 95
_gno. 4
_gp. 497-502
856 4 0 _uhttps://doi.org/10.1111/j.1464-410X.2005.05327.x
_zAvailable from publisher's website
999 _c15381285
_d15381285